| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/14/2023 | Peak Bio, Inc. | | Exercise (in-the-money or at-the-money) | Warrant (Right to Purchase) | 583.3k | $0.60 | $350k | | 08/14/2023 |
| 06/07/2023 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (Right to Buy) | 14k | $23.09 | $323.3k | | 06/07/2023 |
| 04/28/2023 | Peak Bio, Inc. | | Grant | Warrant (Right to Purchase) | 1.9M | $0.60 | $1.1M | | 04/28/2023 |
| 04/28/2023 | Peak Bio, Inc. | | Grant | Convertible Notes | 0 | $1,130,775.00 | $0 | | 04/28/2023 |
| 06/16/2022 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 15k | $6.80 | $102k | | 06/16/2022 |
| 06/29/2021 | PLIANT THERAPEUTICS, INC. | PLRX | Grant | Stock Option (right to buy) | 13.3k | $28.20 | $374.7k | | 06/29/2021 |
| 06/05/2020 | PLIANT THERAPEUTICS, INC. | PLRX | Conversion | Series A Preferred Stock | 1000k | $0.00 | $0 | See footnote | 06/05/2020 |
| 06/05/2020 | PLIANT THERAPEUTICS, INC. | PLRX | Conversion | Common Stock | 139.9k | $0.00 | $0 | See footnote | 06/05/2020 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Grant | Stock Option (right to buy) | 83.7k | $17.00 | $1.4M | | 06/22/2018 |
| 06/13/2018 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (Right to Buy) | 14k | $25.25 | $353.5k | | 06/13/2018 |
| 05/15/2018 | GERON CORP | GERN | Grant | Stock Option (right to buy) | 70k | $3.43 | $240.1k | | 05/15/2018 |
| 12/29/2017 | GERON CORP | GERN | Grant | Common Stock | 10.8k | $0.00 | $0 | | 12/29/2017 |
| 06/20/2017 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 14k | $13.78 | $192.9k | | 06/20/2017 |
| 10/31/2016 | Rezolute, Inc. | RZLT | Grant | Stock Option (right to buy) | 4M | $1.20 | $4.8M | | 10/31/2016 |
| 06/10/2016 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 28k | $10.17 | $284.8k | | 06/10/2016 |